ProMIS Neurosciences Inc. Common Shares (ON) (PMN) is a publicly traded Healthcare sector company. As of September 1, 2026, PMN trades at $13.24 with a market cap of $123.62M and a P/E ratio of -0.59. PMN moved +0.00% today. Year to date, PMN is +91.50%; over the trailing twelve months it is -3.17%. Its 52-week range spans $6.27 to $39.75. Analyst consensus is strong buy with an average price target of $42.46. Rallies surfaces PMN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for PMN, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $13.24 |
| Market Cap | $123.62M |
| P/E Ratio | -0.59 |
| EPS | $-22.61 |
| Dividend Yield | 0.00% |
| 52-Week High | $39.75 |
| 52-Week Low | $6.27 |
| Volume | 16.15K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-39.72M |
| Gross Margin | 0.00% |
6 analysts cover PMN: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $42.46.